Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 10, 2026
Not classified as an open-market trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
other
Code P in the derivative table; not an open-market share purchase
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Nov 11 · filed 3 days later
Not classified as an open-market trade.
Insider filing
Traded Nov 11 · filed 1 day later
Not classified as an open-market trade.
Insider selling
Traded Nov 6 · filed 4 days laterNot reported under a pre-arranged trading plan
A major shareholder of Starling Oncology sold $11.4M of Starling Oncology shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.